We found that the loss of WAVE2 significantly (P < 0.001) inhibited the growth of primary tumors, as determined by tumor volume (Fig. 3A; Supplementary Fig. S3A) and tumor weight (Fig. 3B). Here, WASF2 is linked to neoplasm.